Evidence map›Paper›PMID 41132845›Full record

ReviewActa pharmaceutica Sinica. B2025

The cutting-edge progress of novel biomedicines in ovulatory dysfunction therapy.

Xuzhi Liang, Shiyu Zhang, Dahai Li, Hao Liang, Yueping Yao, Xiuhong Xia, Hang Yu, Mingyang Jiang, Ying Yang, Ming Gao and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Acta pharmaceutica Sinica. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xuzhi LiangDepartment of Gynecology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Shiyu ZhangDepartment of Gynecology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Dahai LiDepartment of Gynecology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Hao LiangDepartment of Gynecology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Yueping YaoDepartment of Gynecology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Xiuhong XiaDepartment of Gynecology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Hang YuDepartment of Gynecology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.
Mingyang JiangDepartment of Orthopaedic Surgery, Yong Loo Lin School of Medicine, National University of Singapore 117510, Singapore.
Ying YangDepartment of Reproductive Medicine, Yunlin First People's Hospital, Yulin 537000, China.
Ming GaoLife Sciences Institute, Guangxi Medical University, Nanning 530021, China.
Lin LiaoDepartment of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning 530021, China.
Jiangtao FanDepartment of Gynecology, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovulatory dysfunction (OD) is one of the main causes of infertility in women of childbearing age, which not only affects their reproductive ability, but also physical and mental health. Traditional treatment strategies have limited efficacies, and the emergence of biomedicines provides a promising alternative solution

Indexed as

Controlled drug releaseDrug delivery systemInfertility therapyNovel biomedicinesOvarian microenvironment reprogrammingOvulatory dysfunction

Identifiers

PMID41132845
PMCPMC12541631

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.